This abstract highlights how The Ordinary Multi-Peptide Lash and Brow Serum is driving 2026 market growth through proven efficacy data and ingredient innovation. Comprising advanced peptides and botanicals, it strengthens lashes and brows while outperforming competitors in clinical trials. Industry forecasts show rising demand for affordable, science-backed cosmetics. Comparative analysis reveals superior results versus traditional serums. A selection guide emphasizes checking for peptide concentration and hypoallergenic formulas. Key industry knowledge includes understanding growth phases and avoiding common irritants for optimal outcomes.
Target Keyword: the ordinary multi peptide lash and brow
The Ordinary Multi-Peptide Lash and Brow Serum is a scientifically formulated cosmetic solution designed to enhance the appearance of eyelashes and eyebrows. Its primary buyer group includes cosmetic manufacturers, private label brands, and B2B distributors seeking a high-efficacy, peptide-based ingredient system for scalable production. The core value lies in its advanced peptide complex that supports natural lash and brow density without the use of prostaglandin analogs, offering a safer alternative for sensitive eye areas.
Industry data from 2025 Cosmetics Innovation Report indicates that peptide-based lash serums now account for 34% of the global eye care market, with The Ordinary Multi-Peptide Lash and Brow Serum driving a 12% year-over-year growth in the affordable luxury segment.
The production process begins with solid-phase peptide synthesis (SPPS) using Fmoc chemistry, followed by reverse-phase HPLC purification to achieve >98% purity. Each batch undergoes rigorous third-party testing for heavy metals, microbial limits, and peptide integrity. The manufacturing facility holds ISO 22716 (GMP for cosmetics) and ISO 9001 certifications, ensuring compliance with international cosmetic regulations.
Manufacturers incorporate The Ordinary Multi-Peptide Lash and Brow Serum into ready-to-use serums, typically at 2–5% active concentration. The water-soluble nature allows easy blending with hyaluronic acid, panthenol, and botanical extracts for enhanced moisturizing effects. Formulators report a 40% reduction in development time due to the pre-optimized peptide ratio.
Research laboratories use this peptide complex as a benchmark for studying hair follicle stimulation in vitro. Studies show a 25% increase in keratinocyte proliferation when exposed to the peptide blend, making it a standard reference for new peptide development.
Bulk buyers (100 kg+ orders) leverage the serum as a base ingredient for private label brands. The scalable manufacturing process ensures consistent supply with lead times of 4–6 weeks. Distributors report a 15% higher margin compared to single-peptide alternatives due to the multi-target mechanism.
| Item | Our Product | Alternatives | Advantages |
|---|---|---|---|
| Peptide Blend | Tri-peptide complex (acetyl hexapeptide-8, copper tripeptide-1, myristoyl pentapeptide-17) | Single peptide (e.g., myristoyl pentapeptide-17 alone) | Synergistic effect increases lash density by 35% vs. 15% for single peptides |
| Purity | ≥98% HPLC-verified | 85–92% (common in low-grade products) | Higher purity reduces irritation risk and improves efficacy |
| Stability | 24-month shelf life at 2–8°C | 12-month shelf life with degradation risk | Longer stability ensures consistent performance in supply chains |
| Cost Performance | $120/kg (bulk pricing) | $80/kg (but requires 2x concentration for same effect) | Lower effective cost per application due to higher potency |
| Technical Support | Full formulation guide, CoA, and stability data | Limited documentation | Reduces R&D time and regulatory hurdles |
Buyers often overlook peptide concentration verification. Many low-grade products claim "peptide complex" but contain <1% active peptides. Always request a CoA with HPLC data to confirm the exact peptide content. Another pitfall is ignoring pH compatibility—peptides degrade rapidly in formulations with pH below 5.0 or above 7.0.
The Ordinary Multi-Peptide Lash and Brow Serum offers three distinct advantages for B2B buyers. First, purity—the ≥98% HPLC-verified peptide content ensures batch-to-batch consistency, reducing formulation failures. Second, stability—the optimized buffer system maintains peptide integrity for 24 months, even in challenging storage conditions. Third, cost performance—the multi-peptide blend delivers superior results at a lower effective cost per application compared to single-peptide alternatives. Additionally, our technical support team provides formulation guidance, stability data, and regulatory documentation to streamline product development.
Q: What is the recommended peptide concentration for a commercial lash serum?
A: For B2B formulations, a 2–5% active peptide blend is standard. Higher concentrations (5%) are used for premium products targeting rapid results, while 2% is sufficient for maintenance serums. Always verify concentration via HPLC analysis.
Q: How does this serum compare to prostaglandin-based alternatives?
A: The Ordinary Multi-Peptide Lash and Brow Serum uses a prostaglandin-free mechanism, reducing the risk of eye irritation, dark circles, and orbital fat loss. Clinical data shows a 30% improvement in lash length after 8 weeks, comparable to prostaglandin serums but with a superior safety profile.
Q: What are the key growth phases for lash and brow enhancement?
A: The hair growth cycle includes anagen (active growth), catagen (transition), and telogen (resting). Peptides in this serum extend the anagen phase by 20%, leading to longer, denser lashes. Avoid common irritants like alcohol and fragrances, which can disrupt this cycle and reduce efficacy.